Skip to main content
SpringerLink
Log in

Verlauf und Therapie bipolarer Störungen

Module für die Gruppenpsychoedukation

Course and Therapy of Bipolar Disorders

Modules for Group Psychoeducation

  • Psychiatrie
  • Published:
psychopraxis. neuropraxis Aims and scope Submit manuscript

Zusammenfassung

Gruppenpsychoedukation ist ein wichtiges Element in der Behandlung von bipolaren Störungen. Ein Programm mit acht Sitzungen wird in dieser Zeitschrift „psychopraxis.neuropraxis“ beschrieben. Die vorliegende Publikation – die zweite von dreien – präsentiert die beiden Module, die dem Verlauf der Störung und den therapeutischen Möglichkeiten gewidmet sind. Es wird ein breiter Überblick über die einschlägige Literatur gegeben.

Abstract

Group psychoeducation is an important element in the treatment of bipolar disorders. A program with eight sessions is described in this journal “psychopraxis.neuropraxis”. The present publication—the second of three—portrays the two modules that are dedicated to the course of the disorder and the therapeutic possibilities. A large overview of the relevant literature is given.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8
Abb. 9
Abb. 10
Abb. 11
Abb. 12

Literatur

  1. Erfurth A (Hrsg) (2003) Weißbuch Bipolare Störungen in Deutschland. Deutsche Gesellschaft für Bipolare Störungen e. V., . ISBN 3‑8311-4521‑0

    Google Scholar 

  2. Kasper S, Kapfhammer HP, Bach M, Butterfield-Meissl C, Erfurth A, Haring C, Hausmann A, Hofmann P, Kalousek M, Klier C, Marksteiner J, Mühlbacher M, Oberlerchner H, Psota G, Rados C, Sachs GM, Windhager E, Winkler J, Wrobel M (2013) Bipolare Störungen. CliniCum Neuropsy 2013(Sonderausgabe November):3–18

    Google Scholar 

  3. Joas E, Bäckman K, Karanti A, Sparding T, Colom F, Pålsson E, Landén M (2020) Psychoeducation for bipolar disorder and risk of recurrence and hospitalization—a within-individual analysis using registry data. Psychol Med 50(6):1043–1049. https://doi.org/10.1017/S0033291719001053

    Article  PubMed  Google Scholar 

  4. Colom F, Vieta E, Martinez-Aran A, Reinares M, Goikolea JM, Benabarre A, Torrent C, Comes M, Corbella B, Parramon G, Corominas J (2003) A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 60(4):402–407. https://doi.org/10.1001/archpsyc.60.4.402

    Article  PubMed  Google Scholar 

  5. Schaub A, Bernhard B, Gauck L (2004) Kognitiv-psychoedukative Therapie bei bipolaren Erkrankungen. Ein Therapiemanual. Hogrefe, Göttingen. ISBN 978-3-8017-1838‑1

    Google Scholar 

  6. Erfurth A, Dobmeier G, Zechendorff M (2005) Kurzpsychoedukation für bipolare Patienten. Thieme, Stuttgart. ISBN 978-3-13-141681‑0

    Google Scholar 

  7. Erfurth A, Michael N, Roestel C, Sachs G (2021) Psychoedukation für bipolare Störungen – die prospektive Life-Chart-Methode. Psychoprax Neuroprax. https://doi.org/10.1007/s00739-020-00689-7

    Article  Google Scholar 

  8. Erfurth A, Arolt V (2003) Das Spektrum bipolarer Störungen. Nervenarzt 74(1):55–71. https://doi.org/10.1007/s00115-003-1473-x

    Article  CAS  PubMed  Google Scholar 

  9. Erfurth A, Sachs G, Perugi G, Tondo L (2014) Athanasios Koukopoulos (1931–2013). Zum Verlauf manisch-depressiver Erkrankungen. Psychoprax Neuroprax 17:5–8. https://doi.org/10.1007/s00739-014-0172-7

    Article  Google Scholar 

  10. Angst J, Merikangas KR, Cui L, Van Meter A, Ajdacic-Gross V, Rössler W (2018) Bipolar spectrum in major depressive disorders. Eur Arch Psychiatry Clin Neurosci 268(8):741–748. https://doi.org/10.1007/s00406-018-0927-x

    Article  CAS  PubMed  Google Scholar 

  11. American Psychiatric Association (2018) Diagnostisches und Statistisches Manual Psychischer Störungen DSM‑5 Bd. 2. Hogrefe, Göttingen (Deutsche Ausgabe herausgegeben von P. Falkai und H.-U. Wittchen, mitherausgegeben von M. Döpfner, W. Gaebel, W. Maier, W. Rief, H. Saß und M. Zaudig)

    Google Scholar 

  12. Akiskal HS, Pinto O (1999) The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am 22:517–534. https://doi.org/10.1016/s0193-953x(05)70093-9

    Article  CAS  PubMed  Google Scholar 

  13. Akiskal HS, Pinto O (2000) The soft bipolar spectrum: footnotes to Kraepelin on the interface of hypomania, temperament and depression. In: Marneros A, Angst J (Hrsg) Bipolar Disorders. Kluwer, Dordrecht, Boston, London, S 37–62. ISBN 978-0-7923-6588‑4

    Google Scholar 

  14. Koukopoulos A, Reginaldi D, Tondo L, Visioli C, Baldessarini RJ (2013) Course sequences in bipolar disorder: depressions preceding or following manias or hypomanias. J Affect Disord 151(1):105–110. https://doi.org/10.1016/j.jad.2013.05.059

    Article  CAS  PubMed  Google Scholar 

  15. Hantouche EG, Erfurth A (2010) Rethinking subthreshold bipolarity: the rebirth of Kahlbaum-Hecker syndrome. Eur Psychiatr 25:170. https://doi.org/10.1016/S0924-9338(10)70170-X

    Article  Google Scholar 

  16. Perugi G, Hantouche E, Vannucchi G, Pinto O (2015) Cyclothymia reloaded: a reappraisal of the most misconceived affective disorder. J Affect Disord 183:119–133. https://doi.org/10.1016/j.jad.2015.05.004

    Article  PubMed  Google Scholar 

  17. Perugi G, Hantouche E, Vannucchi G (2017) Diagnosis and treatment of cyclothymia: the “primacy” of temperament. Curr Neuropharmacol 15(3):372–379. https://doi.org/10.2174/1570159X14666160616120157

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Erfurth A, Sachs G (2015) Mischzustände, Mischbilder und die depressive Episode mit gemischten Merkmalen. Psychoprax Neuroprax 18(2):38–43. https://doi.org/10.1007/s00739-015-0241-6

    Article  Google Scholar 

  19. Tortorella A, Albert U, Nivoli AMA, Erfurth A, Colom F, Maina G (2015) Mixed states: still a modern psychopathological syndrome? J Psychopathol 21:332–340

    Google Scholar 

  20. Erfurth A, Perugi G (2005) Rapid cycling. In: Kasper S, Hirschfeld RMA (Hrsg) Handbook of Bipolar Disorder. Marcel Dekker, Taylor & Francis, New York, S 201–212

    Google Scholar 

  21. Furio MA, Popovic D, Vieta E, Stukalin Y, Hagin M, Torrent C, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G, BRIDGE-II-Mix Study Group (2020) Characterization of rapid cycling bipolar patients presenting with major depressive episode within the BRIDGE-II-MIX study. Bipolar Disord. https://doi.org/10.1111/bdi.12994

    Article  Google Scholar 

  22. Erfurth A, Gerlach AL, Hellweg I, Boenigk I, Michael N, Akiskal HS (2005) Studies on a German (Münster) version of the temperament auto-questionnaire TEMPS-A: construction and validation of the briefTEMPS‑M. J Affect Disord 85(1/2):53–69. https://doi.org/10.1016/S0165-0327(03)00102-2

    Article  PubMed  Google Scholar 

  23. Erfurth A, Gerlach AL, Michael N, Boenigk I, Hellweg I, Signoretta S, Akiskal K, Akiskal HS (2005) Distribution and gender effects of the subscales of a German version of the temperament autoquestionnaire briefTEMPS‑M in a university student population. J Affect Disord 85(1/2):71–76. https://doi.org/10.1016/j.jad.2003.07.003

    Article  PubMed  Google Scholar 

  24. Perugi G, Akiskal HS, Ramacciotti S, Nassini S, Toni C, Milanfranchi A, Musetti L (1999) Depressive comorbidity of panic, social phobic, and obsessive-compulsive disorders re-examined: is there a bipolar II connection? J Psychiatr Res 33(1):53–61. https://doi.org/10.1016/s0022-3956(98)00044-2

    Article  CAS  PubMed  Google Scholar 

  25. Perugi G, Erfurth A, Rihmer Z, Maremmani I, Brieger P (2005) Comorbidity in bipolar disorders. Eur Psychiatry 20:120

    Google Scholar 

  26. Perugi G, Toni C, Akiskal HS (1999) Anxious-bipolar comorbidity. Diagnostic and treatment challenges. Psychiatr Clin North Am 22(3):565–583. https://doi.org/10.1016/s0193-953x(05)70096-4

    Article  CAS  PubMed  Google Scholar 

  27. Shahini M, Shala M, Xhylani P, Gashi S, Borinca I, Erfurth A (2018) Challenging predictions between affective temperaments, depression and anxiety in a Kosovo student community sample. Int J Psychiatry Clin Pract 22(4):282–288. https://doi.org/10.1080/13651501.2018.1426771

    Article  PubMed  Google Scholar 

  28. Schiele MA, Herzog K, Kollert L, Böhnlein J, Repple J, Rosenkranz, Leehr EJ, Ziegler C, Lueken U, Dannlowski U, Pauli P, Arolt V, Zwanzger P, Deckert J, Erfurth A, Domschke K (2020) Affective temperaments (TEMPS-A) in panic disorder and healthy probands: genetic modulation by 5‑HTT variation. World J Biol Psychiatry. https://doi.org/10.1080/15622975.2019.1705999

    Article  PubMed  Google Scholar 

  29. Erfurth A, Sachs G (2020) Angststörungen. In: Steiner M (Hrsg) Angst. WAS, Bd. 113. Leykam, Graz, Wien. ISBN 978-3-7011-8163‑6

    Google Scholar 

  30. Mucci F, Toni C, Favaretto E, Vannucchi G, Marazziti D, Perugi G (2018) Obsessive-compulsive disorder with comorbid bipolar disorders: clinical features and treatment implications. Curr Med Chem 25(41):5722–5730. https://doi.org/10.2174/0929867324666171108145127

    Article  CAS  PubMed  Google Scholar 

  31. Sachs G, Erfurth A (2018) Obsessive compulsive and related disorders: from the biological basis to a rational pharmacological treatment. Int J Neuropsychopharmacol 21(1):59–62. https://doi.org/10.1093/ijnp/pyx101

    Article  PubMed  Google Scholar 

  32. Perugi G, Akiskal HS (2002) The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions. Psychiatr Clin North Am 25(4):713–737. https://doi.org/10.1016/s0193-953x(02)00023-0

    Article  PubMed  Google Scholar 

  33. Fornaro M, Perugi G, Gabrielli F, Prestia D, Mattei C, Vinciguerra V, Fornaro P (2010) Lifetime co-morbidity with different subtypes of eating disorders in 148 females with bipolar disorders. J Affect Disord 121(1/2):147–151. https://doi.org/10.1016/j.jad.2009.06.007

    Article  CAS  PubMed  Google Scholar 

  34. Azorin JM, Bowden CL, Garay RP, Perugi G, Vieta E, Young AH (2010) Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism. Neuropsychiatr Dis Treat 6:37–46. https://doi.org/10.2147/ndt.s6741

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Vyssoki B, Blüml V, Gleiss A, Friedrich F, Kogoj D, Walter H, Zeiler J, Höfer P, Lesch OM, Erfurth A (2011) The impact of temperament in the course of alcohol dependence. J Affect Disord 135(1-3):177–183. https://doi.org/10.1016/j.jad.2011.07.007

    Article  CAS  PubMed  Google Scholar 

  36. Maremmani I, Perugi G, Pacini M, Akiskal HS (2006) Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm. J Affect Disord 93(1-3):1–12. https://doi.org/10.1016/j.jad.2006.02.022

    Article  PubMed  Google Scholar 

  37. Salem B, Vyssoki B, Lesch OM, Erfurth A (2014) Lesch typology and temperament in opioid dependence: a cross sectional study. J Affect Disord 165:203–207. https://doi.org/10.1016/j.jad.2014.04.066

    Article  CAS  PubMed  Google Scholar 

  38. Unseld M, Dworschak G, Tran US, Plener PL, Erfurth A, Walter H, Lesch OM, Kapusta ND (2012) The concept of temperament in psychoactive substance use among college students. J Affect Disord 141(2/3):324–330. https://doi.org/10.1016/j.jad.2012.03.028

    Article  PubMed  Google Scholar 

  39. Amann B, Padberg F, Mergl R, Naber D, Baghai T, Reimers K, El-Giamal N, Erfurth A, Laakmann G (2009) An investigation of temperamental traits in patients with somatoform disorder: do they belong in the affective spectrum? Psychosomatics 50(6):605–612. https://doi.org/10.1176/appi.psy.50.6.605

    Article  PubMed  Google Scholar 

  40. Nicholl BI, Mackay D, Cullen B, Martin DJ, Ul-Haq Z, Mair FS, Evans J, McIntosh AM, Gallagher J, Roberts B, Deary IJ, Pell JP, Smith DJ (2014) Chronic multisite pain in major depression and bipolar disorder: cross-sectional study of 149,611 participants in UK Biobank. BMC Psychiatry 14:350. https://doi.org/10.1186/s12888-014-0350-4

    Article  PubMed  PubMed Central  Google Scholar 

  41. Kasper S, Bach M, Sachs GM, Aigner M, Erfurth A, Glehr R, Konstantinidis A, Lehofer M, Löffler-Stastka H, Quasthoff S, Radoš C, Rießland-Seifert A, Windhager E (2015) Schmerz bei psychiatrischen Erkrankungen. Konsensus-Statement – State of the art. CliniCum Neuropsy 2015(Sonderausgabe November):3–23

    Google Scholar 

  42. Masi G, Perugi G, Toni C, Millepiedi S, Mucci M, Bertini N, Pfanner C (2006) Attention-deficit hyperactivity disorder—bipolar comorbidity in children and adolescents. Bipolar Disord 8(4):373–381. https://doi.org/10.1111/j.1399-5618.2006.00342.x

    Article  PubMed  Google Scholar 

  43. Kutzelnigg A, Erfurth A, Kasper S (2007) Comorbidity of adult ADHD in patients with affective disorders and anxiety. J Neural Transm 114(7):LXVIII

    Google Scholar 

  44. Skala K, Riegler A, Erfurth A, Völkl-Kernstock S, Lesch OM, Walter H (2016) The connection of temperament with ADHD occurrence and persistence into adulthood—An investigation in 18 year old males. J Affect Disord 198:72–77. https://doi.org/10.1016/j.jad.2016.03.051

    Article  CAS  PubMed  Google Scholar 

  45. Vannucchi G, Masi G, Toni C, Dell’Osso L, Erfurth A, Perugi G (2014) Bipolar disorder in adults with Asperger’s syndrome: a systematic review. J Affect Disord 168:151–160. https://doi.org/10.1016/j.jad.2014.06.042

    Article  PubMed  Google Scholar 

  46. Erfurth A, Evers S, Fischera M, Frese A, Gregor N, Heinrichs A (2007) Temperament evaluation in patients with migraine. Cephalalgia 27(6):587

    Google Scholar 

  47. Fornaro M, De Berardis D, De Pasquale C, Indelicato L, Pollice R, Valchera A, Perna G, Iasevoli F, Tomasetti C, Martinotti G, Koshy AS, Fasmer OB, Oedegaard KJ (2015) Prevalence and clinical features associated to bipolar disorder-migraine comorbidity: a systematic review. Compr Psychiatry 56:1–16. https://doi.org/10.1016/j.comppsych.2014.09.020

    Article  PubMed  Google Scholar 

  48. Jamison KR (2000) Suicide and bipolar disorder. J Clin Psychiatry 61(Suppl 9):47–51

    PubMed  Google Scholar 

  49. Skala K, Kapusta ND, Schlaff G, Unseld M, Erfurth A, Lesch OM, Walter H, Akiskal KK, Akiskal HS (2012) Suicidal ideation and temperament: an investigation among college students. J Affect Disord 141(2-3):399–405. https://doi.org/10.1016/j.jad.2012.03.010

    Article  CAS  PubMed  Google Scholar 

  50. Perugi G, Quaranta G, Belletti S, Casalini F, Mosti N, Toni C, Dell’Osso L (2015) General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases. J Affect Disord 170:95–103. https://doi.org/10.1016/j.jad.2014.08.052

    Article  PubMed  Google Scholar 

  51. Colomer L, Anmella G, Vieta E, Grande I (2020) Physical health in affective disorders: a narrative review of the literature. Braz J Psychiatry. https://doi.org/10.1590/1516-4446-2020-1246

    Article  PubMed  Google Scholar 

  52. Epiktet (2014) Handbüchlein der Moral. Philipp Reclam jun, Stuttgart. ISBN 978-3-15-019103‑3 (Aus dem Griechischen übersetzt von Kurt Steinmann)

    Google Scholar 

  53. Sartre JP (2000) Der Existentialismus ein Humanismus. Deutsche Übersetzung von Vincent von Wroblewsky. In: Sartre JP (Hrsg) Der Existenzialismus ist ein Humanismus. Und andere philosophische Essays 1943–1948. Rowohlt, Reinbek

    Google Scholar 

  54. Lazarus RS (1993) From psychological stress to the emotions: a history of changing outlooks. Annu Rev Psychol 44(1):1–22. https://doi.org/10.1146/annurev.ps.44.020193.000245

    Article  CAS  PubMed  Google Scholar 

  55. Ingram RE, Luxton DD (2005) Vulnerability-stress models. In: Hankin BL, Abela JRZ (Hrsg) Development of psychopathology: a vulnerability stress perspective. SAGE, Thousand Oaks, S 32–46

    Chapter  Google Scholar 

  56. Belsky J, Pluess M (2009) Beyond diathesis stress: differential susceptibility to environmental influences. Psychol Bull 135(6):885–908. https://doi.org/10.1037/a0017376

    Article  PubMed  Google Scholar 

  57. Scott J (1995) Psychotherapy for bipolar disorder. Br J Psychiatry 167(5):581–588. https://doi.org/10.1192/bjp.167.5.581

    Article  CAS  PubMed  Google Scholar 

  58. Frank E, Swart HA, Mallinger AG, Thase ME, Weaver EV, Kupfer DJ (1999) Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. J Abnorm Psychol 108(4):579–587. https://doi.org/10.1037//0021-843x.108.4.579

    Article  CAS  PubMed  Google Scholar 

  59. Miklowitz DJ (2008) Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry 165(11):1408–1419. https://doi.org/10.1176/appi.ajp.2008.08040488

    Article  PubMed  PubMed Central  Google Scholar 

  60. Schöttle D, Huber CG, Bock T, Meyer TD (2011) Psychotherapy for bipolar disorder: a review of the most recent studies. Curr Opin Psychiatry 24(6):549–555. https://doi.org/10.1097/YCO.0b013e32834b7c5f

    Article  PubMed  Google Scholar 

  61. Erfurth A, Sachs G (2018) Bipolare Störungen – Ein Update. Psychoprax Neuroprax 21(3):123–127. https://doi.org/10.1007/s00739-018-0470-6

    Article  Google Scholar 

  62. Miklowitz DJ, Efthimiou O, Furukawa TA, Scott J, McLaren R, Geddes JR, Cipriani A (2020) Adjunctive psychotherapy for bipolar disorder: a systematic review and component network meta-analysis. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2020.2993

    Article  PubMed  PubMed Central  Google Scholar 

  63. Panhorst H, Ramacher P, Wagener R, Erfurth A (2001) Psychoedukation bei bipolaren Störungen. Nervenheilkunde 20(Suppl. 2):34–38

    Google Scholar 

  64. Bond K, Anderson IM (2015) Psychoeducation for relapse prevention in bipolar disorder: a systematic review of efficacy in randomized controlled trials. Bipolar Disord 17(4):349–362. https://doi.org/10.1111/bdi.12287

    Article  PubMed  Google Scholar 

  65. Huxley NA, Parikh SV, Baldessarini RJ (2000) Effectiveness of psychosocial treatments in bipolar disorder: state of the evidence. Harv Rev Psychiatry 8(3):126–140

    Article  CAS  Google Scholar 

  66. Alloy LB, Abramson LY, Urosevic S, Walshaw PD, Nusslock R, Neeren AM (2005) The psychosocial context of bipolar disorder: environmental, cognitive, and developmental risk factors. Clin Psychol Rev 25(8):1043–1075. https://doi.org/10.1016/j.cpr.2005.06.006

    Article  PubMed  Google Scholar 

  67. Beynon S, Soares-Weiser K, Woolacott N, Duffy S, Geddes JR (2008) Psychosocial interventions for the prevention of relapse in bipolar disorder: systematic review of controlled trials. Br J Psychiatry 192(1):5–11. https://doi.org/10.1192/bjp.bp.107.037887

    Article  PubMed  Google Scholar 

  68. Sachs GM, Pintsov O, Winklbaur B, Erfurth A, Lenz G, Thau K (2008) Neurocognitive functions as endophenotypes in schizophrenia and bipolar disorder. Eur Psychiatr 23:S142. https://doi.org/10.1016/j.eurpsy.2008.01.876

    Article  Google Scholar 

  69. Harvey PD, Wingo AP, Burdick KE, Baldessarini RJ (2010) Cognition and disability in bipolar disorder: lessons from schizophrenia research. Bipolar Disord 12(4):364–375. https://doi.org/10.1111/j.1399-5618.2010.00831.x

    Article  PubMed  Google Scholar 

  70. Sachs G, Erfurth A (2015) Kognition bei depressiven Störungen. Psychoprax Neuroprax 18(5):172–179. https://doi.org/10.1007/s00739-015-0281-y

    Article  Google Scholar 

  71. Demant KM, Vinberg M, Kessing LV, Miskowiak KW (2015) Effects of short-term cognitive remediation on cognitive dysfunction in partially or fully remitted individuals with bipolar disorder: results of a randomised controlled trial. Plos One 10(6):e127955. https://doi.org/10.1371/journal.pone.0127955

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Veeh J, Kopf J, Kittel-Schneider S, Deckert J, Reif A (2017) Cognitive remediation for bipolar patients with objective cognitive impairment: a naturalistic study. Int J Bipolar Disord 5(1):8. https://doi.org/10.1186/s40345-017-0079-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Sachs G, Maihofer E, Swoboda H, Berg A, Lasser I, Lenz G, Erfurth A (2018) Cognitive dysfunction and remediation in affective disorders. Eur Psychiatr 48:S46. https://doi.org/10.1016/j.eurpsy.2017.12.013

    Article  Google Scholar 

  74. Sachs G, Berg A, Jagsch R, Lenz G, Erfurth A (2020) Predictors of functional outcome in patients with bipolar disorder: effects of cognitive psychoeducational group therapy after 12 months. Front Psychiatry. https://doi.org/10.3389/fpsyt.2020.530026

    Article  PubMed  PubMed Central  Google Scholar 

  75. Cade JF (1949) Lithium salts in the treatment of psychotic excitement. Med J Aust 2(10):349–352. https://doi.org/10.1080/j.1440-1614.1999.06241.x

    Article  CAS  PubMed  Google Scholar 

  76. Schou M, Juel-Nielsen N, Strögren E, Voldby H (1954) The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 17(4):250–260. https://doi.org/10.1136/jnnp.17.4.250

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Baastrup PC, Schou M (1967) Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 16(2):162–172. https://doi.org/10.1001/archpsyc.1967.01730200030005

    Article  CAS  PubMed  Google Scholar 

  78. Angst J, Weis P, Grof P, Baastrup PC, Schou M (1970) Lithium prophylaxis in recurrent affective disorders. Br J Psychiatry 116(535):604–614. https://doi.org/10.1192/bjp.116.535.604

    Article  CAS  PubMed  Google Scholar 

  79. Kukopulos A, Reginaldi D (1973) Does lithium prevent depressions by suppressing manias? Int Pharmacopsychiatry 8(3):152–158. https://doi.org/10.1159/000467986

    Article  CAS  PubMed  Google Scholar 

  80. Kukopulos A, Reginaldi D, Girardi P, Tondo L (1975) Course of manic-depressive recurrences under lithium. Compr Psychiatry 16(6):517–524. https://doi.org/10.1016/s0010-440x(75)80014-9

    Article  CAS  PubMed  Google Scholar 

  81. Greil W, Ludwig-Mayerhofer W, Erazo N, Schöchlin C, Schmidt S, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GA, Sauer H, Tegeler J, Wetterling T (1997) Lithium versus carbamazepine in the maintenance treatment of bipolar disorders—a randomised study. J Affect Disord 43(2):151–161. https://doi.org/10.1016/s0165-0327(96)01427-9

    Article  CAS  PubMed  Google Scholar 

  82. Greil W, Kleindienst N, Erazo N, Müller-Oerlinghausen B (1998) Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol 18(6):455–460. https://doi.org/10.1097/00004714-199812000-00007

    Article  CAS  PubMed  Google Scholar 

  83. Schou M (1999) Perspectives on lithium treatment of bipolar disorder: action, efficacy, effect on suicidal behavior. Bipolar Disord 1(1):5–10. https://doi.org/10.1034/j.1399-5618.1999.10103.x

    Article  CAS  PubMed  Google Scholar 

  84. Kleindienst N, Severus WE, Greil W (2007) Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial. Int Clin Psychopharmacol 22(3):125–131. https://doi.org/10.1097/01.yic.0000224788.21406.c8

    Article  PubMed  Google Scholar 

  85. Coryell W (2009) Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice. Bipolar Disord 11(Suppl 2):77–83. https://doi.org/10.1111/j.1399-5618.2009.00712.x

    Article  CAS  PubMed  Google Scholar 

  86. Grof P, Müller-Oerlinghausen B (2009) A critical appraisal of lithium’s efficacy and effectiveness: the last 60 years. Bipolar Disord 11(Suppl 2):10–19. https://doi.org/10.1111/j.1399-5618.2009.00707.x

    Article  CAS  PubMed  Google Scholar 

  87. Thies-Flechtner K, Müller-Oerlinghausen B, Seibert W, Walther A, Greil W (1996) Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry 29(3):103–107. https://doi.org/10.1055/s-2007-979553

    Article  CAS  PubMed  Google Scholar 

  88. Tondo L, Jamison KR, Baldessarini RJ (1997) Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N Y Acad Sci 836:339–351. https://doi.org/10.1111/j.1749-6632.1997.tb52369.x

    Article  CAS  PubMed  Google Scholar 

  89. Müller-Oerlinghausen B (2001) Arguments for the specificity of the antisuicidal effect of lithium. Eur Arch Psychiatry Clin Neurosci 251(Suppl 2):II72–II75. https://doi.org/10.1007/BF03035132

    Article  PubMed  Google Scholar 

  90. Tondo L, Hennen J, Baldessarini RJ (2001) Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand 104(3):163–172. https://doi.org/10.1034/j.1600-0447.2001.00464.x

    Article  CAS  PubMed  Google Scholar 

  91. Tondo L, Baldessarini RJ (2018) Antisuicidal effects in mood disorders: are they unique to lithium? Pharmacopsychiatry 51(5):177–188. https://doi.org/10.1055/a-0596-7853

    Article  CAS  PubMed  Google Scholar 

  92. Emrich HM, Dose M, von Zerssen D (1985) The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affect Disord 8(3):243–250. https://doi.org/10.1016/0165-0327(85)90022-9

    Article  CAS  PubMed  Google Scholar 

  93. Grunze H, Erfurth A, Amann B, Giupponi G, Kammerer C, Walden J (1999) Intravenous valproate loading in acutely manic and depressed bipolar I patients. J Clin Psychopharmacol 19(4):303–309. https://doi.org/10.1097/00004714-199908000-00003

    Article  CAS  PubMed  Google Scholar 

  94. Cipriani A, Reid K, Young AH, Macritchie K, Geddes J (2013) Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003196.pub2

    Article  PubMed  PubMed Central  Google Scholar 

  95. Erfurth A, Walden J, Grunze H (1998) Lamotrigine in the treatment of schizoaffective disorder. Neuropsychobiology 38(3):204–205. https://doi.org/10.1159/000026540

    Article  CAS  PubMed  Google Scholar 

  96. Calabrese JR, Vieta E, Shelton MD (2003) Latest maintenance data on lamotrigine in bipolar disorder. Eur Neuropsychopharmacol 13(Suppl 2):S57–S66. https://doi.org/10.1016/s0924-977x(03)00079-8

    Article  CAS  PubMed  Google Scholar 

  97. Hahn CG, Gyulai L, Baldassano CF, Lenox RH (2004) The current understanding of lamotrigine as a mood stabilizer. J Clin Psychiatry 65(6):791–804. https://doi.org/10.4088/jcp.v65n0610

    Article  CAS  PubMed  Google Scholar 

  98. Muzina DJ, Elhaj O, Gajwani P, Gao K, Calabrese JR (2005) Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder. Acta Psychiatr Scand Suppl 426:21–28. https://doi.org/10.1111/j.1600-0447.2005.00523.x

    Article  CAS  Google Scholar 

  99. Hirschfeld RM, Kasper S (2004) A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder. Int J Neuropsychopharmacol 7(4):507–522. https://doi.org/10.1017/S1461145704004651

    Article  CAS  PubMed  Google Scholar 

  100. Dietrich DE, Kropp S, Emrich HM (2003) Oxcarbazepine in the treatment of affective and schizoaffective disorders. Fortschr Neurol Psychiatr 71(5):255–264. https://doi.org/10.1055/s-2003-39065

    Article  CAS  PubMed  Google Scholar 

  101. Vasudev A, Macritchie K, Vasudev K, Watson S, Geddes J, Young AH (2011) Oxcarbazepine for acute affective episodes in bipolar disorder. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004857.pub2

    Article  PubMed  Google Scholar 

  102. Erfurth A, Kammerer C, Grunze H, Normann C, Walden J (1998) An open label study of gabapentin in the treatment of acute mania. J Psychiatr Res 32(5):261–264. https://doi.org/10.1016/S0022-3956(98)00010-7

    Article  CAS  PubMed  Google Scholar 

  103. Altshuler LL, Keck PE Jr, McElroy SL, Suppes T, Brown ES, Denicoff K, Frye M, Gitlin M, Hwang S, Goodman R, Leverich G, Nolen W, Kupka R, Post R (1999) Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord 1(1):61–65. https://doi.org/10.1034/j.1399-5618.1999.10113.x

    Article  CAS  PubMed  Google Scholar 

  104. Vieta E, Martinez-Arán A, Nieto E, Colom F, Reinares M, Benabarre A, Gastó C (2000) Adjunctive gabapentin treatment of bipolar disorder. Eur Psychiatry 15(7):433–437. https://doi.org/10.1016/s0924-9338(00)00514-9

    Article  CAS  PubMed  Google Scholar 

  105. Wang PW, Santosa C, Schumacher M, Winsberg ME, Strong C, Ketter TA (2002) Gabapentin augmentation therapy in bipolar depression. Bipolar Disord 4(5):296–301. https://doi.org/10.1034/j.1399-5618.2002.01211.x

    Article  CAS  PubMed  Google Scholar 

  106. Perugi G, Toni C, Frare F, Ruffolo G, Moretti L, Torti C, Akiskal HS (2002) Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity? J Clin Psychopharmacol 22(6):584–591. https://doi.org/10.1097/00004714-200212000-00008

    Article  CAS  PubMed  Google Scholar 

  107. Houghton KT, Forrest A, Awad A, Atkinson LZ, Stockton S, Harrison PJ, Geddes JR, Cipriani A (2017) Biological rationale and potential clinical use of gabapentin and pregabalin in bipolar disorder, insomnia and anxiety: protocol for a systematic review and meta-analysis. BMJ Open 7(3):e13433. https://doi.org/10.1136/bmjopen-2016-013433

    Article  PubMed  PubMed Central  Google Scholar 

  108. Schaffer LC, Schaffer CB, Miller AR, Manley JL, Piekut JA, Nordahl TE (2013) An open trial of pregabalin as an acute and maintenance adjunctive treatment for outpatients with treatment resistant bipolar disorder. J Affect Disord 147(1/3):407–410. https://doi.org/10.1016/j.jad.2012.09.005

    Article  CAS  PubMed  Google Scholar 

  109. Erfurth A, Kuhn G (2000) Topiramate monotherapy in the maintenance treatment of bipolar I disorder: effects on mood, weight and serum lipids. Neuropsychobiology 42(Suppl 1):50–51. https://doi.org/10.1159/000054854

    Article  CAS  PubMed  Google Scholar 

  110. Pecuch PW, Erfurth A (2001) Topiramate in the treatment of acute mania. J Clin Psychopharmacol 21(2):243–244. https://doi.org/10.1097/00004714-200104000-00022

    Article  CAS  PubMed  Google Scholar 

  111. Chengappa KN, Gershon S, Levine J (2001) The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. Bipolar Disord 3(5):215–232

    Article  CAS  Google Scholar 

  112. Erfurth A, Grunze H (1998) New perspectives in the treatment of acute mania: a single case report. Prog Neuropsychopharmacol Biol Psychiatry 22(6):1053–1059. https://doi.org/10.1016/s0278-5846(98)00061-x

    Article  CAS  PubMed  Google Scholar 

  113. Grunze H, Erfurth A, Schäfer M, Amann B, Meyendorf R (1999) Elektrokonvulsionstherapie in der Behandlung der schweren Manie – Kasuistik und Wissensstand. Nervenarzt 70(7):662–667. https://doi.org/10.1007/s001150050493

    Article  CAS  PubMed  Google Scholar 

  114. Erfurth A, Michael N, Mostert C, Arolt V (2000) Euphoric mania and rapid transcranial magnetic stimulation. Am J Psychiatry 157(5):835–836. https://doi.org/10.1176/appi.ajp.157.5.835-a

    Article  CAS  PubMed  Google Scholar 

  115. Michael N, Erfurth A (2004) Treatment of bipolar mania with right prefrontal rapid transcranial magnetic stimulation. J Affect Disord 78(3):253–257. https://doi.org/10.1016/S0165-0327(02)00308-7

    Article  PubMed  Google Scholar 

  116. Erfurth A, Michael N, Arolt V (2001) Therapie der bipolaren Depression. Nervenheilkunde 20(Suppl. 2):7–10

    Google Scholar 

  117. Michael N, Erfurth A, Arolt V (2001) Elektrokrampftherapie und transkranielle Magnetstimulation zur Behandlung bipolarer Störungen. Nervenheilkunde 20(Suppl. 2):30–33

    Google Scholar 

  118. Erfurth A, Michael N, Grunze H, Walden J (2001) Behandlung affektiver Mischzustände und des “rapid cycling” – Alternativen zur Lithiumtherapie. Nervenheilkunde 20(Suppl. 2):39–40

    Google Scholar 

  119. Erfurth A, Sachs G (2017) Aggression und serotoninerge Dysfunktion: Neurochemische Befunde und Therapiemöglichkeiten. Psychoprax Neuroprax 20(1):23–27. https://doi.org/10.1007/s00739-016-0366-2

    Article  Google Scholar 

  120. Erfurth A (2017) Agitation: a central challenge in psychiatry. World J Biol Psychiatry 18(1):3–4. https://doi.org/10.1080/15622975.2016.1237043

    Article  PubMed  Google Scholar 

  121. Amodeo G, Fagiolini A, Sachs G, Erfurth A (2017) Older and newer strategies for the pharmacological treatment of agitation in schizophrenia and bipolar disorder. CNS Neurol Disord Drug Targets 16(8):885–890. https://doi.org/10.2174/1871527316666170919115507

    Article  CAS  PubMed  Google Scholar 

  122. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L (1980) Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol 13(4):156–167. https://doi.org/10.1055/s-2007-1019628

    Article  CAS  PubMed  Google Scholar 

  123. Reginaldi D, Tondo L, Floris G, Pignatelli A, Kukopulos A (1981) Poor prophylactic lithium response due to antidepressants. Int Pharmacopsychiatry 16(2):124–128. https://doi.org/10.1159/000468484

    Article  CAS  PubMed  Google Scholar 

  124. Reginaldi D, Tondo L, Caliari B, Minnai GP, Kukopulos A (1982) The role of antidepressants in rapid cyclicity. Adv Biochem Psychopharmacol 32:363–367

    CAS  PubMed  Google Scholar 

  125. Perugi G, Pacchiarotti I, Mainardi C, Verdolini N, Menculini G, Barbuti M, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Vieta E, BRIDGE-II-MIX Study Group (2019) Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis. Eur Neuropsychopharmacol 29(7):825–834. https://doi.org/10.1016/j.euroneuro.2019.06.001

    Article  CAS  PubMed  Google Scholar 

  126. Novak W, Erfurth A (2017) Therapie depressiver Störungen mit selektiven Serotonin-Rückaufnahme-Inhibitoren (SSRI). Psychoprax Neuroprax 20(1):28–41. https://doi.org/10.1007/s00739-016-0371-5

    Article  Google Scholar 

  127. Novak W, Sachs G, Erfurth A (2017) Diagnostik und Therapie depressiver Störungen. 1. Teil. Psychoprax Neuroprax 20(2):60–65. https://doi.org/10.1007/s00739-017-0378-6

    Article  Google Scholar 

  128. Novak W, Sachs G, Erfurth A (2017) Diagnostik und Therapie depressiver Störungen. 2. Teil. Psychoprax Neuroprax 20(3):124–129. https://doi.org/10.1007/s00739-017-0389-3

    Article  Google Scholar 

  129. Himmelhoch JM, Thase ME, Mallinger AG, Houck P (1991) Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 148(7):910–916. https://doi.org/10.1176/ajp.148.7.910

    Article  CAS  PubMed  Google Scholar 

  130. Thase ME (2012) The role of monoamine oxidase inhibitors in depression treatment guidelines. J Clin Psychiatry 73(Suppl 1):10–16. https://doi.org/10.4088/JCP.11096su1c.02

    Article  CAS  PubMed  Google Scholar 

  131. Schmauss M, Erfurth A (1989) Indikationen für eine Therapie mit MAO-Hemmern. Psychiatr Prax 16(Suppl 1):2–6

    PubMed  Google Scholar 

  132. Erfurth A, Michael N, Stadtland C, Arolt V (2002) Bupropion as add-on strategy in difficult-to-treat bipolar depressive patients. Neuropsychobiology 45(Suppl 1):33–36. https://doi.org/10.1159/000049259

    Article  CAS  PubMed  Google Scholar 

  133. Erfurth A (2016) Milnacipran. Ein neuer Serotonin-Noradrenalin-Wiederaufnahmehemmer bereichert die antidepressive Therapie. Thieme Drug Rep 18:4–12

    Google Scholar 

  134. Schmauss M, Erfurth A (1996) Kombinationstherapien bei Therapieresistenz auf Antidepressiva: eine Übersicht. Fortschr Neurol Psychiatr 64(10):390–402. https://doi.org/10.1055/s-2007-996583

    Article  CAS  PubMed  Google Scholar 

  135. Erfurth A, Möller HJ (2000) Vorgehen bei Antidepressiva-Nonrespondern. In: Möller HJ (Hrsg) Therapie psychiatrischer Erkrankungen, 2. Aufl. Thieme, Stuttgart, S 407–413. ISBN 3‑432-99651‑9

    Google Scholar 

  136. Köhnlein O, Lutz R, Erfurth A, Messer T, Hiemke C, Schmauss M (2004) Therapeutisches Drug Monitoring: Wann macht es in der Praxis Sinn? Neurol & Psychiater 12:46–50

    Google Scholar 

  137. Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P (2018) Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017. Pharmacopsychiatry 51(e1):1–2. https://doi.org/10.1055/s-0037-1600991

    Article  Google Scholar 

  138. Erfurth A, Konstantinidis A (2008) Polypharmacy in bipolar disorder: does it make sense? Ann Gen Psychiatry 7(1):48. https://doi.org/10.1186/1744-859X-7-S1-S48

    Article  Google Scholar 

  139. Adachi N, Azekawa T, Edagawa K, Goto E, Hongo S, Kato M, Katsumoto E, Kikuchi T, Kubota Y, Miki K, Nakagawa A, Tsuboi T, Ueda H, Watanabe K, Watanabe Y, Yasui-Furukori N, Yoshimura R (2020) Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients’ and practitioners’ parameters in the MUSUBI study. Hum Psychopharmacol 22:e2764. https://doi.org/10.1002/hup.2764

    Article  Google Scholar 

  140. Nasrallah HA, Churchill CM, Hamdan-Allan GA (1988) Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. Am J Psychiatry 145(11):1455–1456. https://doi.org/10.1176/ajp.145.11.1455

    Article  CAS  PubMed  Google Scholar 

  141. Grohmann R, Koch R, Schmidt LG (1990) Extrapyramidal symptoms in neuroleptic recipients. Agents Actions Suppl 29:71–82. https://doi.org/10.1007/978-3-0348-7292-8_7

    Article  CAS  PubMed  Google Scholar 

  142. Michael N, Sourgens H, Arolt V, Erfurth A (2002) Severe tardive dyskinesia in affective disorders: treatment with vitamin E and C. Neuropsychobiology 46(Suppl 1):28–30. https://doi.org/10.1159/000068019

    Article  CAS  PubMed  Google Scholar 

  143. Gao K, Kemp DE, Ganocy SJ, Gajwani P, Xia G, Calabrese JR (2008) Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. J Clin Psychopharmacol 28(2):203–209. https://doi.org/10.1097/JCP.0b013e318166c4d5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  144. Erfurth A, Amann B, Grunze H (1998) Female genital disorder as adverse symptom of lamotrigine treatment. A serotoninergic effect? Neuropsychobiology 38(3):200–201. https://doi.org/10.1159/000026538

    Article  CAS  PubMed  Google Scholar 

  145. Cohen S, Kühn KU, Bender S, Erfurth A, Gastpar M, Murafi A, Rothermundt M, Signerski J, Sträter B, Teusch L, Weig W, Welling A, Westheide J, Huber TJ (2007) Sexual impairment in psychiatric inpatients: focus on depression. Pharmacopsychiatry 40(2):58–63. https://doi.org/10.1055/s-2007-970143

    Article  CAS  PubMed  Google Scholar 

  146. Westheide J, Cohen S, Bender S, Cooper-Mahkorn D, Erfurth A, Gastpar M, Huber TJ, Maier W, Murafi A, Rothermundt M, Signerski J, Sträter B, Teusch L, Weig W, Welling A, Kühn KU (2007) Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication. Pharmacopsychiatry 40(4):140–145. https://doi.org/10.1055/s-2007-981480

    Article  CAS  PubMed  Google Scholar 

  147. García-Blanco A, García-Portilla MP, Fuente-Tomás L, Batalla M, Sánchez-Autet M, Arranz B, Safont G, Arqués S, Livianos L, Sierra P (2020) Sexual dysfunction and mood stabilizers in long-term stable patients with bipolar disorder. J Sex Med 17(5):930–940. https://doi.org/10.1016/j.jsxm.2020.01.032

    Article  CAS  PubMed  Google Scholar 

  148. Barton BB, Zagler A, Engl K, Rihs L, Musil R (2020) Prevalence of obesity, metabolic syndrome, diabetes and risk of cardiovascular disease in a psychiatric inpatient sample: results of the Metabolism in Psychiatry (MiP) Study. Eur Arch Psychiatry Clin Neurosci 270(5):597–609. https://doi.org/10.1007/s00406-019-01043-8

    Article  PubMed  Google Scholar 

  149. Bai Y, Yang H, Chen G, Gao K (2020) Acceptability of acute and maintenance pharmacotherapy of bipolar disorder: a systematic review of randomized, double-blind, placebo-controlled clinical trials. J Clin Psychopharmacol 40(2):167–179

    Article  Google Scholar 

  150. Klein CC, Topalian AG, Starr B, Welge J, Blom T, Starr C, Deetz I, Turner H, Sage J, Utecht J, Fornari V, Patino Duran L, Higdon C, Sutton JJ, Sorter MT, Correll CU, DelBello MP (2020) The importance of second-generation antipsychotic-related weight gain and adherence barriers in youth with bipolar disorders: patient, parent, and provider perspectives. J Child Adolesc Psychopharmacol 30(6):376–380. https://doi.org/10.1089/cap.2019.0184

    Article  PubMed  Google Scholar 

  151. Nielsen RE, Banner J, Jensen SE (2020) Cardiovascular disease in patients with severe mental illness. Nat Rev Cardiol. https://doi.org/10.1038/s41569-020-00463-7

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 1. Abteilung für Psychiatrie und Psychotherapeutische Medizin, Klinik Hietzing, Wolkersbergenstr. 1, 1130, Wien, Österreich

    Andreas Erfurth

  2. Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Krankenhaus Elbroich, Düsseldorf, Deutschland

    Nikolaus Michael

  3. Universitätsklinik für Psychiatrie und Psychotherapie, Wien, Österreich

    Gabriele Sachs

  4. Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Münster, Münster, Deutschland

    Andreas Erfurth, Nikolaus Michael & Cornelia Roestel

Authors
  1. Andreas Erfurth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nikolaus Michael
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cornelia Roestel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gabriele Sachs
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Erfurth.

Ethics declarations

Interessenkonflikt

A. Erfurth, N. Michael, C. Roestel und G. Sachs geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Hinweis des Verlags

Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Erfurth, A., Michael, N., Roestel, C. et al. Verlauf und Therapie bipolarer Störungen. psychopraxis. neuropraxis 24, 156–165 (2021). https://doi.org/10.1007/s00739-021-00718-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00739-021-00718-z

Schlüsselwörter

Keywords

Search

Navigation